Market Place
Sourcing Support
Hepatitis C: Anvisa warns about counterfeit drug
01 Jun 2020 //
ANVISA
AbbVie’s HCV treatment receives first for shorter treatment cycle
30 Sep 2019 //
IN-PHARMATECHNOLOGIST
Regulatory barriers limit alternative state drug payment models
18 Sep 2019 //
BIOSPAHRMADIVE
NHS England sees off AbbVie`s Hep C legal challenge
22 Jan 2019 //
PM LIVE
Supreme Court rebuffs appeals from Merck, Gilead in 2 high-profile drug battles
08 Jan 2019 //
FIERCE PHARMA
AbbVie`s latest hep C push highlights Mavyret`s time-to-cure advantage
13 Dec 2018 //
FIERCE PHARMA
What do Martin Shkreli, Gilead and Takeda have in common?
06 Dec 2018 //
ENDPTS
Express Scripts plans `Flex` formulary focused on authorized generics
14 Nov 2018 //
BIOPHARMA DIVE
Merck asks SCOTUS for its $200M in Gilead patent dues
26 Sep 2018 //
FIERCE PHARMA
AbbVie`s facing kickbacks scrutiny with Biogen, Sanofi, Gilead
26 Sep 2018 //
FIERCE PHARMA
Gilead to Sell Cheaper Versions of Drug That Sparked Cost Debate
25 Sep 2018 //
BLOOMBERG
Gilead Subsidiary to Launch Epclusa and Harvoni
24 Sep 2018 //
Gilead to launch generic versions of its hepatitis drugs
24 Sep 2018 //
Gilead`s top execs Milligan and Martin stepping down
26 Jul 2018 //
FIERCE PHARMA
Two pre-grant patent oppositions filed on Gilead’s Hepatitis C medicines
09 Jul 2018 //
HINDU BUSINESS LINE
Enyo Pharma raises $47M to bring hepatitis B, NASH drug to phase 2
04 Jun 2018 //
FIERCE PHARMA
Celgene, AbbVie extract pricing gains as Gilead, J&J meds net less
04 Apr 2018 //
FIERCE PHARMA
Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict
21 Feb 2018 //
REUTERS
Retail drug spending grew just 1.3% last year, CMS says
06 Dec 2017 //
FIERCE PHARMA
Here`s What`s Has Happened in the HCV Space Lately
06 Oct 2017 //
NASDAQ
Maryland team lands $6M from NIH to fund novel HCV vaccine
13 Jun 2017 //
FIERCE PHARMA
PM meets with Gilead Sciences representatives to fight hepatitis
20 Apr 2017 //
THEUBPOST
Tonix Pharma Reports Results U.S. FDA Initial Cross-Disciplinary Breakthrough
11 Apr 2017 //
GLOBENEWSWIRE
Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion
11 Apr 2017 //
NASDAQ
Gilead notches pediatric use for Sovaldi, Harvoni as sales fade among adults
08 Apr 2017 //
FIERCE PHARMA
FDA Approves First Hep C Drugs for Kids
07 Apr 2017 //
PHARMAMANUFACTURING
DTC #FierceMadness tipoff: McDreamy, Viagra and Valeant`s big toe
15 Mar 2017 //
FIERCE PHARMA
Gilead pushes hep C testing in baby boomers as its blockbusters plummet
22 Feb 2017 //
FIERCE PHARMA
How Gilead (GILD) Just Lost $9 Billion in Market Value This Week
09 Feb 2017 //
BIOSPACE
Value investors pile into Gilead expecting strong long-term growth: report
07 Feb 2017 //
FIERCE PHARMA
Breakthrough hep C meds carry risk for liver failure, death: report
26 Jan 2017 //
FIERCE PHARMA
Two new hepatitis C therapies fast-tracked in Europe
25 Jan 2017 //
PMLIVE
Why the Government Should Pay $156 Billion to Own Gilead (GILD)
17 Jan 2017 //
BIOSPACE
Biologics Enter Top Selling Drugs’ List
29 Dec 2016 //
ECONOMIC TIMES
Gilead Ordered to Pay $2.54 Billion to Merck over Hepatitis C Patents
16 Dec 2016 //
STAT
J&J`s Xarelto, AbbVie`s Humira shelled out most on doc payments last year
14 Dec 2016 //
FIERCE PHARMA
Gilead and Express Scripts make peace in hep C with 2017 formulary deal
14 Dec 2016 //
FIERCE PHARMA
Top of 2017`s pharma heap? Pfizer, Novartis, Roche
08 Dec 2016 //
FIERCE PHARMA
Gilead Comes Around on Truvada PrEP Marketing, Opening a New World of HIV Sales
01 Dec 2016 //
FIERCE PHARMA
Gilead`s R&D Woes Could Make it an Attractive Target for Allergan & Pfizer
18 Nov 2016 //
BIOSPACE
Harvoni, Lantus top Medicare, Medicaid drug spend as U.S. total hits $457B
15 Nov 2016 //
FIERCE PHARMA
Pharma already balks at Germany`s tough pricing regime
14 Nov 2016 //
FIERCE PHARMA
Recent Success in HCV Treatment Brings Relief to Patients
07 Nov 2016 //
DRUG DEVELOPMENT
Gilead Drops Another Bombshell, Will Shift R&D Cash Away From Hep C
03 Nov 2016 //
BIOSPACE
Gilead sales of Hepatitis C drugs slump
01 Nov 2016 //
MARKETWATCH
Surprise: Gilead`s hep C wonder Harvoni costs less in U.S. than in EU, Japan
22 Sep 2016 //
FIERCE PHARMA
Pfizer, Amgen most likely to bid for Medivation: analysts
02 Jul 2016 //
FIERCE PHARMA
U.S. Judge Frees Gilead from $200M in Damages to Merck
15 Jun 2016 //
PHARMACEUTICAL MANUFACTURING
Gilead Judge Re-Opens Case Amid Claim Merck Scientist Lied
03 May 2016 //
BLOOMBERG
Gilead`s hep C slowdown cues Q1 miss on sales, profit
30 Apr 2016 //
FIERCE PHARMA
New York attorney general sues insurer for restricting hepatitis C drugs
19 Apr 2016 //
STAT
AbbVie looks to battle Gilead with new hep C data
18 Apr 2016 //
FIERCE BIOTECH
Gilead hep C cocktail cures a pocket of drug-resistant cases
15 Apr 2016 //
FIERCE BIOTECH
EU extends safety review of chronic Hep C treatments
15 Apr 2016 //
REUTERS
Will new drug spending figures increase pressure on pharma?
14 Apr 2016 //
FIERCE PHARMA
Gilead keeps Martin`s pay going strong at $18.8M in his last year as CEO
07 Apr 2016 //
FIERCE PHARMA
Gilead contractor PharmaChem starts $120M Bahamas expansion
05 Apr 2016 //
FIERCE PHARMA MANUFACTURING
Blockbuster Hepatitis C drug now under price control
01 Apr 2016 //
ECONOMIC TIMES
Gilead meds face little threat from hep C rivals Merck, BMS and AbbVie: analyst
31 Mar 2016 //
FIERCE PHARMA MARKETING
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
25 Mar 2016 //
REUTERS
